# Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma

> **NCT01252758** · PHASE2 · WITHDRAWN · sponsor: **Acerus Pharmaceuticals Corporation**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** albuterol sufate DPI (TBS-7) dose 1
- **DRUG:** albuterol sufate DPI (TBS-7) dose 2
- **DRUG:** albuterol sufate DPI (TBS-7) dose 3
- **OTHER:** Placebo
- **DRUG:** Albuterol
- **DRUG:** Albuterol

## Key facts

- **NCT ID:** NCT01252758
- **Lead sponsor:** Acerus Pharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2013-04
- **Final completion:** 2015-10
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252758, "Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01252758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*